Marinus Pharmaceuticals (MEX:MRNS) Days Sales Outstanding : 37.48 (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Marinus Pharmaceuticals Days Sales Outstanding?

Marinus Pharmaceuticals's average Accounts Receivable for the three months ended in Jun. 2024 was MXN60.6 Mil. Marinus Pharmaceuticals's Revenue for the three months ended in Jun. 2024 was MXN147.6 Mil. Hence, Marinus Pharmaceuticals's Days Sales Outstanding for the three months ended in Jun. 2024 was 37.48.

The historical rank and industry rank for Marinus Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

MEX:MRNS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.88 Med: 62.03 Max: 349.7
Current: 48.88

During the past 12 years, Marinus Pharmaceuticals's highest Days Sales Outstanding was 349.70. The lowest was 48.88. And the median was 62.03.

MEX:MRNS's Days Sales Outstanding is ranked better than
69.91% of 874 companies
in the Biotechnology industry
Industry Median: 72.61 vs MEX:MRNS: 48.88

Marinus Pharmaceuticals's Days Sales Outstanding declined from Jun. 2023 (131.51) to Jun. 2024 (37.48).

Marinus Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Marinus Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marinus Pharmaceuticals Days Sales Outstanding Chart

Marinus Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

349.71

50.25

65.29

65.31

Marinus Pharmaceuticals Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															131.51	58.65	51.98	43.96	37.48

Competitive Comparison of Marinus Pharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, Marinus Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marinus Pharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marinus Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Marinus Pharmaceuticals's Days Sales Outstanding falls into.

Marinus Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Marinus Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (123.761	+	64.485)	/	2 )	/	526.015	*	365
=	94.123					/	526.015	*	365
=	65.31

Marinus Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (58.303	+	62.93)	/	2 )	/	147.587	*	365 / 4
=	60.6165					/	147.587	*	365 / 4
=	37.48

Marinus Pharmaceuticals (MEX:MRNS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Marinus Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Marinus Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Marinus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinus Pharmaceuticals Inc (MEX:MRNS) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

MRNS:USA 0JYL:UK 61Y:Germany

Address

100 Matsonford Road, Suite 500, 5 Radnor Corporate Center, Radnor, PA, USA, 19087

Website

https://www.marinuspharma.com

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.